Factor XI promotes hemostasis in factor IX-deficient mice.

Area of Science:

• Coagulation cascade research
• Hemostasis and thrombosis
• Hematology

Background:

• Human Factor XI (FXI) deficiency is linked to bleeding disorders.
• FXI-deficient mice previously showed no hemostatic defect, but recent studies suggest a moderate defect.
• Hemophilia B is caused by Factor IX (FIX) deficiency.

Purpose of the Study:

• To investigate the role of FXI in bleeding.
• To examine FXI's effect in mice with normal FIX levels and in a murine model of hemophilia B (FIX-deficient mice).

Main Methods:

• Utilized a saphenous vein bleeding (SVB) model in wild-type, FIX-deficient (F9^-), and FXI-deficient (F11^-/-) mice.
• Manipulated FXI levels in F11^-/- mice via infusion or overexpression.
• Assessed hemostasis in F9^- mice after FXI manipulation.

Main Results:

• FIX-deficient mice exhibited a significant bleeding defect in the SVB model.
• FXI-deficient mice showed no difference in hemostasis compared to wild-type mice.
• FXI infusion or overexpression in FIX-deficient mice improved hemostasis, even with a FIX-binding site-deficient FXI variant.

Conclusions:

• FXI does not appear to cause a hemostatic defect in mice lacking it.
• Elevated FXI levels enhance hemostasis in FIX-deficient mice.
• FXI may improve hemostasis in hemophilia B through FIX-independent mechanisms.